Provided by Tiger Trade Technology Pte. Ltd.

Allogene Therapeutics Inc.

2.21
-0.2300-9.43%
Post-market: 2.220.0100+0.45%19:57 EDT
Volume:4.42M
Turnover:9.80M
Market Cap:538.75M
PE:-2.55
High:2.43
Open:2.38
Low:2.11
Close:2.44
52wk High:2.80
52wk Low:0.8621
Shares:243.78M
Float Shares:168.00M
Volume Ratio:0.48
T/O Rate:2.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8652
EPS(LYR):-0.8652
ROE:-53.42%
ROA:-26.82%
PB:1.84
PE(LYR):-2.55

Loading ...

Mar 14, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 14, 2024

Major Issues Report

Form 8-K - Current report
Mar 14, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Feb 23, 2024

Correspondence

Form CORRESP - Correspondence
Feb 16, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 31, 2024

Major Issues Report

Form 8-K - Current report
Jan 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2024

Major Issues Report

Form 8-K - Current report
Dec 20, 2023

Major Issues Report

Form 8-K - Current report
Dec 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2023

Correspondence

Form CORRESP - Correspondence
Nov 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2023

Major Issues Report

Form 8-K - Current report
Oct 26, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Oct 18, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Oct 16, 2023

Major Issues Report

Form 8-K - Current report